Cinnamaldehyde-Containing Organoarsenic Prodrug with Synergistic Anticancer Activity via Redox Dyshomeostasis
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Hui Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory for Chemical Biology of Fujian Province, The MOE Laboratory of Spectrochemical Analysis & Instrumentation, and Department of Chemi…. Hauptthemen laut MEDLINE: Prodrugs, Acrolein, Antineoplastic Agents, Arsenicals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China, Youth Topnotch Talent Program of the Fujian Young Eagle Plan.
Abstract (Originalsprache)
The severe occurrence and mortality of cancer and the gradually increasing failure rate of traditional chemotherapeutic agents call for the search for alternative strategies for cancer therapy. Herein, we report the development of a small-molecule prodrug TAO-CA by conjugating a trivalent organoarsenical (TAO) with a natural product cinnamaldehyde (CA) via an acetal linkage. This prodrug is able to be activated under the mildly acidic environment of the tumor to release the two parent drugs for simultaneously inhibiting the activity of thioredoxin reductase (TrxR) and reducing the cellular level of glutathione (GSH), resulting in intracellular redox dyshomeostasis and consequent cancer cell apoptosis for effective inhibition of tumor growth. The mechanism and efficacy of this prodrug have been validated by a series of in vitro and in vivo experiments, demonstrating the promising potential of our strategy, the integration of the prodrug approach, and synergistic redox dyshomeostasis induction for effective cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory for Chemical Biology of Fujian Province, The MOE Laboratory of Spectrochemical Analysis & Instrumentation, and Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen Uni…
- Xiamen Key Laboratory of Translational Medical of Digestive System Tumor, Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital of Xiamen University, School of Medici…
ORCID-Profile: Hongyu Lin, Jinhao Gao
Förderung
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
- Youth Topnotch Talent Program of the Fujian Young Eagle Plan
Zitieren
APA
Xiong, H., Yan, J., Zhang, J., Jiang, Y., Chi, X., Lin, H., & Gao, J. (2025). Cinnamaldehyde-Containing Organoarsenic Prodrug with Synergistic Anticancer Activity via Redox Dyshomeostasis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00778
Vancouver
Xiong H, Yan J, Zhang J, Jiang Y, Chi X, Lin H, et al. Cinnamaldehyde-Containing Organoarsenic Prodrug with Synergistic Anticancer Activity via Redox Dyshomeostasis. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00778
BibTeX
@article{Xiong2025,
author = {Xiong, Hui and Yan, Jingxue and Zhang, Jun and Jiang, Yuhang and Chi, Xiaoqin and Lin, Hongyu and Gao, Jinhao},
title = {Cinnamaldehyde-Containing Organoarsenic Prodrug with Synergistic Anticancer Activity via Redox Dyshomeostasis},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00778}
}
EUVIMED